Jointown Pharmaceutical Group Co., Ltd

SHSE:600998 Stock Report

Market Cap: CN¥22.3b

Jointown Pharmaceutical Group Future Growth

Future criteria checks 3/6

Jointown Pharmaceutical Group is forecast to grow earnings and revenue by 21.8% and 13.5% per annum respectively. EPS is expected to grow by 18.7% per annum. Return on equity is forecast to be 12.1% in 3 years.

Key information

21.8%

Earnings growth rate

18.7%

EPS growth rate

Healthcare earnings growth22.4%
Revenue growth rate13.5%
Future return on equity12.1%
Analyst coverage

Low

Last updated27 Jun 2024

Recent future growth updates

Recent updates

Earnings Working Against Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Share Price

Aug 26
Earnings Working Against Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Share Price

These 4 Measures Indicate That Jointown Pharmaceutical Group (SHSE:600998) Is Using Debt Reasonably Well

Aug 01
These 4 Measures Indicate That Jointown Pharmaceutical Group (SHSE:600998) Is Using Debt Reasonably Well

Jointown Pharmaceutical Group (SHSE:600998) Has More To Do To Multiply In Value Going Forward

Jun 07
Jointown Pharmaceutical Group (SHSE:600998) Has More To Do To Multiply In Value Going Forward

Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Earnings Are Not Doing Enough For Some Investors

May 21
Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Earnings Are Not Doing Enough For Some Investors

Calculating The Intrinsic Value Of Jointown Pharmaceutical Group Co., Ltd (SHSE:600998)

Apr 05
Calculating The Intrinsic Value Of Jointown Pharmaceutical Group Co., Ltd (SHSE:600998)

Earnings and Revenue Growth Forecasts

SHSE:600998 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026208,9083,750N/A-5193
12/31/2025189,2113,160N/A6,0195
12/31/2024168,3122,759N/A-11,3874
6/30/2024147,9532,039821,029N/A
3/31/2024148,5192,1513,1554,116N/A
12/31/2023150,1402,1743,6994,748N/A
9/30/2023151,8422,1705,2176,257N/A
6/30/2023151,7972,1595,4096,559N/A
3/31/2023147,3662,1942,3953,611N/A
12/31/2022140,4242,0852,7433,986N/A
9/30/2022133,2601,7823,6384,886N/A
6/30/2022128,4111,5451,3452,656N/A
3/31/2022124,9292,1411,8623,234N/A
12/31/2021122,4072,4482,0733,459N/A
9/30/2021122,6343,3392821,907N/A
6/30/2021121,4913,9883,1134,802N/A
3/31/2021116,3153,2582,0093,574N/A
12/31/2020110,8603,0751,9873,444N/A
9/30/2020106,4382,8492,9304,117N/A
6/30/2020102,4172,2422,0253,152N/A
3/31/2020102,0071,9762,3493,480N/A
12/31/201999,4971,7271,5762,768N/A
9/30/201996,7691,5881,4792,737N/A
6/30/201993,1161,5471,8823,123N/A
3/31/201989,5891,4465831,833N/A
12/31/201887,1361,341-5931,222N/A
9/30/201883,2301,262-1,949-231N/A
6/30/201880,1631,189-3,942-2,213N/A
3/31/201877,3391,481N/A-2,221N/A
12/31/201773,9431,446N/A-1,012N/A
9/30/201770,7831,374N/A-2,586N/A
6/30/201767,9991,360N/A-198N/A
3/31/201764,925921N/A1,382N/A
12/31/201661,557877N/A431N/A
9/30/201658,367777N/A1,748N/A
6/30/201655,482754N/A193N/A
3/31/201653,091718N/A-783N/A
12/31/201549,589695N/A436N/A
9/30/201546,895640N/A-1,088N/A
6/30/201545,049602N/A-1,287N/A
3/31/201543,171566N/A-312N/A
12/31/201441,068561N/A-172N/A
9/30/201439,273533N/A-450N/A
6/30/201437,189509N/A-702N/A
3/31/201435,150493N/A-1,230N/A
12/31/201333,438478N/A138N/A
9/30/201332,097464N/A-1,105N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600998's forecast earnings growth (21.8% per year) is above the savings rate (2.9%).

Earnings vs Market: 600998's earnings (21.8% per year) are forecast to grow slower than the CN market (21.9% per year).

High Growth Earnings: 600998's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 600998's revenue (13.5% per year) is forecast to grow faster than the CN market (13.4% per year).

High Growth Revenue: 600998's revenue (13.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600998's Return on Equity is forecast to be low in 3 years time (12.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y